A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients

Both genetic variants and messenger RNA (mRNA) expression of DNA repair and tumor suppressor genes have been investigated as molecular markers for therapy outcome. However, the phenotypic impact of genetic variants often remained unclear, thus the rationale of their use in risk prediction may be lim...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Carcinogenesis
Main Authors: Woelfelschneider, Andreas, Popanda, Odilia, Lilla, Carmen, Linseisen, Jakob, Mayer, Claudia, Celebi, Oktay, Debus, Jürgen, Bartsch, Helmut, Chang-Claude, Jenny, Schmezer, Peter
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2008
Assuntos:
Molecular Epidemiology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110227/
https://ncbi.nlm.nih.gov/pubmed/18332046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgn067
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares